U.S. Markets open in 8 hrs 5 mins

OncoMed Pharmaceuticals, Inc. (OMED)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
3.84+0.08 (+2.13%)
At close: 4:00PM EDT
People also watch
Currency in USD

Valuation Measures

Market Cap (intraday) 5144.47M
Enterprise Value 3N/A
Trailing P/E -1.35
Forward P/E 1-2.36
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)5.78
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Mar 31, 2017
Profit Margin 0.00%
Operating Margin (ttm)-395.34%
Management Effectiveness
Return on Assets (ttm)-33.24%
Return on Equity (ttm)N/A
Income Statement
Revenue (ttm)25.02M
Revenue Per Share (ttm)0.72
Quarterly Revenue Growth (yoy)-2.20%
Gross Profit (ttm)25.15M
EBITDA -97.14M
Net Income Avi to Common (ttm)-98.5M
Diluted EPS (ttm)-2.85
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)156.93M
Total Cash Per Share (mrq)4.17
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.27
Book Value Per Share (mrq)-1.08
Cash Flow Statement
Operating Cash Flow (ttm)-101.8M
Levered Free Cash Flow (ttm)-48.79M

Trading Information

Stock Price History
Beta 2.79
52-Week Change 3-68.51%
S&P500 52-Week Change 319.54%
52 Week High 313.27
52 Week Low 33.14
50-Day Moving Average 33.59
200-Day Moving Average 36.77
Share Statistics
Avg Vol (3 month) 3517.05k
Avg Vol (10 day) 3265.35k
Shares Outstanding 537.62M
Float 20.63M
% Held by Insiders 161.74%
% Held by Institutions 137.20%
Shares Short 31.8M
Short Ratio 32.58
Short % of Float 36.53%
Shares Short (prior month) 32.22M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A